Partner data shows how PharmaJet technology can improve DNA vaccine delivery and outperform needle/syringe, while providing safety & improved comfort.

A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic ...

Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways -- ways that have important implications for the development of ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

Results from OVATION 2 Study of IMNN-001 to be highlighted in late-breaking acceptanceCompany also announces FDA End-of-Phase 2 in-person meeting ...

MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...

Lytic induction therapy has been developed to selectively kill EBV-positive cancer cells by triggering viral reactivation ...

A research team led by the University of California, Irvine has engineered an efficient new enzyme that can produce a ...

People of Ashkenazi Jewish descent are at higher risk of developing pancreatic cancer because they are more likely than other ...

The global DNA diagnostics market is poised for remarkable expansion, with sales expected to reach USD 27,094.2 million in 2024 and a projected climb to USD 57,420.1 million by 2034. This growth ...

Boston is a city recognized worldwide for its cutting-edge advancements in science and medicine, especially in the field of ...